tiprankstipranks
Trending News
More News >
Immutep’s Efti Combination Shows Promising Results in Lung Cancer Trial
PremiumCompany AnnouncementsImmutep’s Efti Combination Shows Promising Results in Lung Cancer Trial
1M ago
Immutep announces response rates from INSIGHT-003 trial
Premium
The Fly
Immutep announces response rates from INSIGHT-003 trial
2M ago
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
2M ago
Immutep reports Q3 cash receipts from customers A$12,000
PremiumThe FlyImmutep reports Q3 cash receipts from customers A$12,000
2M ago
Immutep’s Promising Clinical Developments and Strategic Collaborations Earn a Buy Rating
Premium
Ratings
Immutep’s Promising Clinical Developments and Strategic Collaborations Earn a Buy Rating
3M ago
Immutep announces first patient dosed in TACTI-004 Phase III trial
Premium
The Fly
Immutep announces first patient dosed in TACTI-004 Phase III trial
3M ago
Immutep promotes Christian Mueller to CDO, CMO Florian Vogl to depart
PremiumThe FlyImmutep promotes Christian Mueller to CDO, CMO Florian Vogl to depart
5M ago
Immutep reports Q2 cash receipts from customers A$8,000
Premium
The Fly
Immutep reports Q2 cash receipts from customers A$8,000
5M ago
Immutep announces patient enrollment completed for EFTISARC-NEO Phase II trial
Premium
The Fly
Immutep announces patient enrollment completed for EFTISARC-NEO Phase II trial
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100